Joy Stutrud, PA
Physician Assistant · Inver Grove Heights, MNNPI 1619374030
Payments from drug & device makers
Across 22 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$81
- Sanofi$47
- Regeneron Healthcare Solutions, Inc.$39
- Pfizer$29
- Lilly USA, LLC$27
- Galderma Laboratories, L.p.$19
- plus $99 from 7 others
What the payments were for
- Food & beverage$341100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 5 | $81 |
| Sanofi | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Pfizer | 2 | $29 |
| Lilly USA, LLC | 2 | $27 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Novartis | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Amgen | 1 | $11 |
How this compares
$341 in reported general payments places this provider in the 80th percentile of 3,121 physician assistant providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $225,278 |
| Ketoconazole | 161 | $2,403 |
| Betamethasone Dipropionate | 83 | $2,394 |
| Clindamycin Phosphate | 55 | $2,274 |
| Clobetasol Propionate | 39 | $1,217 |
| Metronidazole | 24 | $1,014 |
| Fluorouracil | 11 | $859 |
| Doxycycline Hyclate | 14 | $738 |
| Doxycycline Monohydrate | 35 | $653 |
| Fluocinolone Acetonide | 14 | $652 |
| Triamcinolone Acetonide | 77 | $609 |
| Gentamicin Sulfate | 20 | $572 |
| Mupirocin | 44 | $332 |
| Hydrocortisone | 56 | $242 |
| Mometasone Furoate | 12 | $120 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Inver Grove Heights
- Sara RobeckBloomington$274K
- Natalie IkemanEdina$170K
- Adam HetzBlaine$156K
- Sarah SchettleRochester$150K
- John IsenbergMaple Grove$92K
- Kenneth MitchellWoodbury$87K
- Jennifer SutherlandMinneapolis$65K
- George FroehleMinneapolis$61K
- Skye PeltierMinneapolis$36K
- Devanie SutterSt Louis Park$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.